The Food and Drug Administration issued an emergency use authorization on Wednesday for two over-the-counter coronavirus tests that can be used routinely.
Why it matters: Although the FDA had already issued authorizations for several at-home coronavirus tests, most recently earlier this month, the tests greenlighted this week can be used multiple times instead of once.
Stay on top of the latest market trends and economic insights with Axios Markets. Subscribe for free
Details: The Quidel QuickVue At-Home OTC COVID-19 test and multiple versions of the Abbott BinaxNOW test received authorizations for at-home use.
The FDA also authorized the BD Veritor System for Rapid Detection of SARS-CoV-2 for use at point-of-care locations.
What they're saying: “Screening testing, especially with the over-the-counter tests authorized today, is an important part of the country’s pandemic response—many schools, workplaces, communities, and other entities are setting up testing programs to quickly screen for COVID-19," Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health, said in a press release.
Like this article? Get more from Axios and subscribe to Axios Markets for free.